Compile Data Set for Download or QSAR

Found 2 hits Enz. Inhib. hit(s) with Target = 'fMet-Leu-Phe receptor' and Ligand = 'BDBM450260'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450260 (US10676431, Example 23 | US11117861, Example 23) Show SMILES CS(=O)(=O)Nc1ncccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H19ClF3N5O4S/c1-37(35,36)31-21-14(3-2-9-28-21)13-5-7-18(20(27)19(13)26)32-10-8-17(22(32)33)30-23(34)29-16-6-4-12(24)11-15(16)25/h2-7,9,11,17H,8,10H2,1H3,(H,28,31)(H2,29,30,34)/t17-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	700	n/a	n/a	n/a	n/a
TBA					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				Citation and Details BindingDB Entry DOI: 10.7270/Q2ZK5KV9
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450260 (US10676431, Example 23 | US11117861, Example 23) Show SMILES CS(=O)(=O)Nc1ncccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H19ClF3N5O4S/c1-37(35,36)31-21-14(3-2-9-28-21)13-5-7-18(20(27)19(13)26)32-10-8-17(22(32)33)30-23(34)29-16-6-4-12(24)11-15(16)25/h2-7,9,11,17H,8,10H2,1H3,(H,28,31)(H2,29,30,34)/t17-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	700	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair